• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于活性药物成分合成的系统化反应设计方法。

A systematic reactor design approach for the synthesis of active pharmaceutical ingredients.

机构信息

Institute of Energy and Process Systems Engineering, Technische Universität Braunschweig, Franz-Liszt-Straße 35, 38106 Braunschweig, Germany; PVZ-Center of Pharmaceutical Engineering, Franz-Liszt-Straße 35A, 38106 Braunschweig, Germany; International Max Planck Research School for Advanced Methods in Process and Systems Engineering, Sandtorstraße 1, 39106 Magdeburg, Germany.

Institute of Energy and Process Systems Engineering, Technische Universität Braunschweig, Franz-Liszt-Straße 35, 38106 Braunschweig, Germany; PVZ-Center of Pharmaceutical Engineering, Franz-Liszt-Straße 35A, 38106 Braunschweig, Germany.

出版信息

Eur J Pharm Biopharm. 2018 May;126:75-88. doi: 10.1016/j.ejpb.2017.05.007. Epub 2017 May 20.

DOI:10.1016/j.ejpb.2017.05.007
PMID:28536050
Abstract

Today's highly competitive pharmaceutical industry is in dire need of an accelerated transition from the drug development phase to the drug production phase. At the heart of this transition are chemical reactors that facilitate the synthesis of active pharmaceutical ingredients (APIs) and whose design can affect subsequent processing steps. Inspired by this challenge, we present a model-based approach for systematic reactor design. The proposed concept is based on the elementary process functions (EPF) methodology to select an optimal reactor configuration from existing state-of-the-art reactor types or can possibly lead to the design of novel reactors. As a conceptual study, this work summarizes the essential steps in adapting the EPF approach to optimal reactor design problems in the field of API syntheses. Practically, the nucleophilic aromatic substitution of 2,4-difluoronitrobenzene was analyzed as a case study of pharmaceutical relevance. Here, a small-scale tubular coil reactor with controlled heating was identified as the optimal set-up reducing the residence time by 33% in comparison to literature values.

摘要

当今竞争激烈的制药行业迫切需要加速从药物开发阶段过渡到药物生产阶段。在这个过渡过程的核心是化学反应器,它促进了活性药物成分(API)的合成,其设计可以影响后续的处理步骤。受此挑战启发,我们提出了一种基于模型的系统反应器设计方法。该概念基于基本过程功能(EPF)方法,从现有最先进的反应器类型中选择最佳的反应器配置,或者可能导致新型反应器的设计。作为概念性研究,这项工作总结了将 EPF 方法应用于 API 合成领域最佳反应器设计问题的基本步骤。实际上,用亲核芳香取代 2,4-二氟硝基苯作为药物相关性的案例研究进行了分析。在这里,确定了带有控制加热的小型管式线圈反应器作为最佳设置,与文献值相比,将停留时间缩短了 33%。

相似文献

1
A systematic reactor design approach for the synthesis of active pharmaceutical ingredients.一种用于活性药物成分合成的系统化反应设计方法。
Eur J Pharm Biopharm. 2018 May;126:75-88. doi: 10.1016/j.ejpb.2017.05.007. Epub 2017 May 20.
2
Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.实现连续制造:药物合成、后处理及分离的技术与方法。2014年5月20 - 21日连续制造研讨会
J Pharm Sci. 2015 Mar;104(3):781-91. doi: 10.1002/jps.24252. Epub 2014 Dec 2.
3
Kilogram-scale prexasertib monolactate monohydrate synthesis under continuous-flow CGMP conditions.公斤级普拉克索单乳酸单水合物在连续流 CGMP 条件下的合成。
Science. 2017 Jun 16;356(6343):1144-1150. doi: 10.1126/science.aan0745.
4
Emerging Trends in Flow Chemistry and Applications to the Pharmaceutical Industry.流动化学的新兴趋势及其在制药工业中的应用。
J Med Chem. 2019 Jul 25;62(14):6422-6468. doi: 10.1021/acs.jmedchem.8b01760. Epub 2019 Mar 8.
5
Active pharmaceutical ingredient (API) production involving continuous processes--a process system engineering (PSE)-assisted design framework.活性药物成分(API)生产中的连续工艺——一种过程系统工程(PSE)辅助设计框架。
Eur J Pharm Biopharm. 2012 Oct;82(2):437-56. doi: 10.1016/j.ejpb.2012.07.001. Epub 2012 Jul 20.
6
Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.连续制药生产中的控制系统工程。2014年5月20 - 21日,连续制造研讨会
J Pharm Sci. 2015 Mar;104(3):832-9. doi: 10.1002/jps.24311. Epub 2014 Dec 26.
7
How development and manufacturing will need to be structured--heads of development/manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.研发与制造将如何进行架构安排——研发/制造负责人。2014年5月20 - 21日连续制造研讨会。
J Pharm Sci. 2015 Mar;104(3):850-64. doi: 10.1002/jps.24286. Epub 2015 Jan 28.
8
Continuous flow technology vs. the batch-by-batch approach to produce pharmaceutical compounds.连续流技术与分批生产药物化合物的方法对比。
Expert Rev Clin Pharmacol. 2018 Jan;11(1):5-13. doi: 10.1080/17512433.2018.1413936. Epub 2017 Dec 15.
9
Early chemical development at Legacy Wyeth Research.礼来惠氏研究公司早期的化学开发。
Drug Discov Today. 2011 Jan;16(1-2):81-8. doi: 10.1016/j.drudis.2010.11.008. Epub 2010 Nov 25.
10
Continuous processes for the production of pharmaceutical intermediates and active pharmaceutical ingredients.用于生产药物中间体和活性药物成分的连续工艺。
Curr Opin Drug Discov Devel. 2007 Nov;10(6):738-45.